EU conference 'The Microbial Threat'

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

EU conference 'The Microbial Threat'. / Mevius, D J; Sprenger, M J; Wegener, Henrik Caspar.

I: International Journal of Antimicrobial Agents, Bind 11, Nr. 2, 02.1999, s. 101-5.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Mevius, DJ, Sprenger, MJ & Wegener, HC 1999, 'EU conference 'The Microbial Threat'', International Journal of Antimicrobial Agents, bind 11, nr. 2, s. 101-5.

APA

Mevius, D. J., Sprenger, M. J., & Wegener, H. C. (1999). EU conference 'The Microbial Threat'. International Journal of Antimicrobial Agents, 11(2), 101-5.

Vancouver

Mevius DJ, Sprenger MJ, Wegener HC. EU conference 'The Microbial Threat'. International Journal of Antimicrobial Agents. 1999 feb;11(2):101-5.

Author

Mevius, D J ; Sprenger, M J ; Wegener, Henrik Caspar. / EU conference 'The Microbial Threat'. I: International Journal of Antimicrobial Agents. 1999 ; Bind 11, Nr. 2. s. 101-5.

Bibtex

@article{cf0c5bc4c15b429f9062915c67a55299,
title = "EU conference 'The Microbial Threat'",
abstract = "A global or European strategy should be developed to deal with increasing antimicrobial resistance. This strategy includes surveillance of antimicrobial resistance and monitoring of the use of antimicrobial agents in animals and humans. In animals, surveillance should be focussed on potential transfer of resistant, zoonotic, food-born pathogens and resistance genes to humans. In humans the surveillance should be clinically relevant. Guidelines for rational therapy should be implemented and 'antibiotic teams' should be installed in each hospital to evaluate the prescription of antibiotics and its compliance with guidelines. Keeping animals for food production involves the responsibility for their well being. This includes treatment of infections. However, the use of feed additive, growth-promoting antimicrobials related to therapeutics in human medicine, should be banned immediately. Research aimed at intervention strategies for antimicrobial resistance should be given a high priority with adequate financing both nationally and in Europe. Well co-ordinated European research programmes should have priority; this includes the need to install a European multidisciplinary scientific advisory group.",
keywords = "Animals, Drug Resistance, Microbial, European Union, Humans, Population Surveillance, Congresses",
author = "Mevius, {D J} and Sprenger, {M J} and Wegener, {Henrik Caspar}",
year = "1999",
month = feb,
language = "English",
volume = "11",
pages = "101--5",
journal = "International Journal of Antimicrobial Agents",
issn = "0924-8579",
publisher = "Elsevier",
number = "2",

}

RIS

TY - JOUR

T1 - EU conference 'The Microbial Threat'

AU - Mevius, D J

AU - Sprenger, M J

AU - Wegener, Henrik Caspar

PY - 1999/2

Y1 - 1999/2

N2 - A global or European strategy should be developed to deal with increasing antimicrobial resistance. This strategy includes surveillance of antimicrobial resistance and monitoring of the use of antimicrobial agents in animals and humans. In animals, surveillance should be focussed on potential transfer of resistant, zoonotic, food-born pathogens and resistance genes to humans. In humans the surveillance should be clinically relevant. Guidelines for rational therapy should be implemented and 'antibiotic teams' should be installed in each hospital to evaluate the prescription of antibiotics and its compliance with guidelines. Keeping animals for food production involves the responsibility for their well being. This includes treatment of infections. However, the use of feed additive, growth-promoting antimicrobials related to therapeutics in human medicine, should be banned immediately. Research aimed at intervention strategies for antimicrobial resistance should be given a high priority with adequate financing both nationally and in Europe. Well co-ordinated European research programmes should have priority; this includes the need to install a European multidisciplinary scientific advisory group.

AB - A global or European strategy should be developed to deal with increasing antimicrobial resistance. This strategy includes surveillance of antimicrobial resistance and monitoring of the use of antimicrobial agents in animals and humans. In animals, surveillance should be focussed on potential transfer of resistant, zoonotic, food-born pathogens and resistance genes to humans. In humans the surveillance should be clinically relevant. Guidelines for rational therapy should be implemented and 'antibiotic teams' should be installed in each hospital to evaluate the prescription of antibiotics and its compliance with guidelines. Keeping animals for food production involves the responsibility for their well being. This includes treatment of infections. However, the use of feed additive, growth-promoting antimicrobials related to therapeutics in human medicine, should be banned immediately. Research aimed at intervention strategies for antimicrobial resistance should be given a high priority with adequate financing both nationally and in Europe. Well co-ordinated European research programmes should have priority; this includes the need to install a European multidisciplinary scientific advisory group.

KW - Animals

KW - Drug Resistance, Microbial

KW - European Union

KW - Humans

KW - Population Surveillance

KW - Congresses

M3 - Journal article

C2 - 10221412

VL - 11

SP - 101

EP - 105

JO - International Journal of Antimicrobial Agents

JF - International Journal of Antimicrobial Agents

SN - 0924-8579

IS - 2

ER -

ID: 172850156